» Articles » PMID: 2429319

Functional Role for the 170- to 180-kDa Glycoprotein Specific to Drug-resistant Tumor Cells As Revealed by Monoclonal Antibodies

Overview
Specialty Science
Date 1986 Oct 1
PMID 2429319
Citations 123
Authors
Affiliations
Soon will be listed here.
Abstract

An overexpression of the plasma membrane glycoprotein of relative molecular size 170-180 kDa is consistently found in different multidrug-resistant human and animal cell lines, although the functional role of the protein in multidrug resistance is not known. Two monoclonal antibodies that interfere with biochemical functions were generated against the human myelogenous leukemia K-562 cells resistant to adriamycin (K-562/ADM). These antibodies, designated MRK16 and MRK17, are specifically reactive to K-562/ADM and a human ovarian cancer cell line resistant to adriamycin (2780AD). MRK16 modulated vincristine and actinomycin D transport in the resistant cells, while MRK17 specifically inhibited the growth of the resistant cells. Both antibodies recognized the 170- to 180-kDa glycoprotein. These data indicate that the 170- to 180-kDa glycoprotein is involved, directly or indirectly, in the drug transport mechanisms and the proliferation of multidrug-resistant tumor cell lines.

Citing Articles

Mutational analysis reveals the importance of residues of the access tunnel inhibitor site to human P-glycoprotein (ABCB1)-mediated transport.

Salazar P, Murakami M, Ranganathan N, Durell S, Ambudkar S Protein Sci. 2024; 33(9):e5155.

PMID: 39194126 PMC: 11350596. DOI: 10.1002/pro.5155.


ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery.

Schulz J, Hartz A, Bauer B Pharmacol Rev. 2023; 75(5):815-853.

PMID: 36973040 PMC: 10441638. DOI: 10.1124/pharmrev.120.000025.


Augmented Therapeutic Potential of EC-Synthetic Retinoids in Caco-2 Cancer Cells Using an In Vitro Approach.

Abdelaal M, Ibrahim E, Elnagar M, Soror S, Haffez H Int J Mol Sci. 2022; 23(16).

PMID: 36012706 PMC: 9409216. DOI: 10.3390/ijms23169442.


Clinical and biological impact of ATP-binding cassette transporter activity in adult acute myeloid leukemia.

Sourdeau E, Suner L, Memoli M, Genthon A, Feger F, Soret L Haematologica. 2022; 108(1):61-68.

PMID: 35924580 PMC: 9827156. DOI: 10.3324/haematol.2022.280676.


Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors.

Rabbani N, Thornalley P Int J Mol Sci. 2022; 23(5).

PMID: 35269594 PMC: 8910005. DOI: 10.3390/ijms23052453.


References
1.
Beck W, Mueller T, Tanzer L . Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res. 1979; 39(6 Pt 1):2070-6. View

2.
Skovsgaard T . Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells. Cancer Res. 1978; 38(12):4722-7. View

3.
Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y . Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 1981; 41(5):1967-72. View

4.
Galfre G, Milstein C . Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol. 1981; 73(Pt B):3-46. DOI: 10.1016/0076-6879(81)73054-4. View

5.
Eva A, ROBBINS K, Andersen P, Srinivasan A, Tronick S, Reddy E . Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells. Nature. 1982; 295(5845):116-9. DOI: 10.1038/295116a0. View